We help medicinal chemistry drug discovery biotech companies also in the preclinical biomarker R&D for their drug candidates. We also help diagnostic technology companies to validate their assay in clinical settings. Our partners already: Vichem, Solvo, Biostatin, Bioblocks
Reference:
KPS and the medicinal chemistry company Vichem Ltd. have several projects to identify novel compounds and companion diagnostics for the treatment of lung cancer, to detect and discover novel targets in cancer stem cells and to develop novel compounds and companion diagnostics against influenza in collaboration with the MaxPlanck Institute.
Investigators of KPS have adopted the functional multidrug resistance technology of SOLVO Inc. to be applicable in solid tumor tissues and rheumatoid arthritis. KPS has also organized the biobanking of blood and urine samples for SOLVO’s tumor marker project.
KPS was testing the significance of M2PK as potential molecular target of somatostatin analogue developed by Biostatin Ltd.